Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo by Reyes-Aldasoro, C. C. et al.
Reyes-Aldasoro, C. C., Wilson, I., Prise, V. E., Barber, P. R., Ameer-Beg, M., Vojnovic, B., 
Cunningham, V. J. & Tozer, G. M. (2008). Estimation of apparent tumor vascular permeability from 
multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo. Microcirculation, 15(1), 
pp. 65-79. doi: 10.1080/10739680701436350 
City Research Online
Original citation: Reyes-Aldasoro, C. C., Wilson, I., Prise, V. E., Barber, P. R., Ameer-Beg, M., 
Vojnovic, B., Cunningham, V. J. & Tozer, G. M. (2008). Estimation of apparent tumor vascular 
permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo. 
Microcirculation, 15(1), pp. 65-79. doi: 10.1080/10739680701436350 
Permanent City Research Online URL: http://openaccess.city.ac.uk/5510/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
 1 
Title: 
Estimation of Apparent Tumour Vascular Permeability from Multiphoton Fluorescence 
Microscopic Images of P22 Rat Sarcomas in vivo. 
 
Authors: 
Constantino Carlos Reyes-Aldasoro a; Ian Wilson b; Vivien E. Prise b; Paul R. Barber b; 
Simon M. Ameer-Beg c; Borivoj Vojnovic b; Vincent J. Cunningham d; Gillian M. Tozer a  
Address: 
a Cancer Research UK Tumour Microcirculation Group, Academic Unit of Surgical 
Oncology, The University of Sheffield, Sheffield, UK 
b Mount Vernon Hospital, Gray Cancer Institute, Northwood, Middlesex, UK 
c The Richard Dimbleby Department of Cancer Research, Division of Cancer Studies, 
King's College, London, London, UK  
d GlaxoSmithKline, Clinical Imaging Centre, Imperial College, London, UK 
 
*Corresponding author.   
E-mail address:  c.reyes@sheffield.ac.uk 
Telephone:  00 44 (0) 114 271 2850 
Fax:   00 44 (0) 114 271 3791 
 
Running Title: 
Measurement of Tumour Vascular Permeability  
 
Acknowledgements: 
This work has been supported by Cancer Research UK. 
 
 2 
ABSTRACT 
Objective: To develop an image processing-based method to quantify the rate of 
extravasation of fluorescent contrast agents from tumour microvessels, and to 
investigate the effect of the tumour vascular disrupting agent, combretastatin A-4-P (CA-
4-P), on apparent tumour vascular permeability to 40 kDa fluorescein isothiocyanate 
(FITC) labelled dextran. 
Methods: Extravasation of FITC-dextran was imaged in three dimensions over time 
within P22 sarcomas growing in dorsal skin flap ‘window chambers’ in BDIX rats using 
multiphoton fluorescence microscopy. Image processing techniques were used to 
segment the data into intra- and extra-vascular regions or classes. Quantitative 
estimates of the tissue influx (vascular leakage) rate constant, Ki, were obtained from the 
time courses of the fluorescence intensities in the two classes. Apparent permeability, P, 
was calculated, assuming Ki = PS/V, where S is vascular surface area in tumour volume 
V.  
Results: Combining image processing and kinetic analysis algorithms with multi-photon 
fluorescence microscopy enabled quantification of the rate of tumour vascular leakage, 
averaged over a large number of vessels. Treatment with CA-4-P caused a significant 
increase in Ki from 1.13 ± 0.33 to 2.59 ± 0.20 (s
-1 x 10-4; mean ± SEM), equivalent to an 
increase in P from 12.76 ± 3.36 to 30.94 ± 2.64 (cm s-1 x 10-7).  
Conclusions: A methodology was developed that provided evidence for a CA-4-P-
induced increase in tumour macromolecular vascular permeability, likely to be central to 
its anti-cancer activity. 
 
Keywords: Vascular permeability, multiphoton fluorescence microscopy, combretastatin, 
segmentation, tumour vascular disrupting agents. 
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INTRODUCTION 
Vascular permeability of blood vessels in tumours is of great interest for the treatment 
of cancer for three main reasons. First, the vascular wall represents a major barrier to 
the entry of high molecular weight anti-cancer agents into tumour tissue [1]; second, it 
controls the tumour microenvironment thus affecting tumour progression [2] and third, 
changes in its barrier function may provide an early indicator of vascular damage 
following treatment with anti-angiogenic or vascular disrupting drugs [3]. Despite the 
importance of tumour vascular permeability [4], little attention has been paid to its 
quantitative measurement. In some cases, permeability is simply observed by using a 
marker, for example Evans blue, an albumin-binding dye, and determining if the marker 
is present or absent in a specific tissue region [5-7]. Although this is useful in normal 
tissues, where any significant extravasation is suggestive of vascular damage or in 
determining breakdown of the blood-brain barrier following tumour growth, it is not 
appropriate for determining the effects of treatment in tumours, where even unperturbed 
blood vessels are highly permeable. In this case, a fully quantitative method is required.  
The first aim of the present work was to develop methodology to quantify the rate of 
extravasation of an intravenously-administered macromolecular fluorescent marker from 
microvessels over a large tumour volume, using multiphoton fluorescence microscopy. 
The advent of multiphoton fluorescence microscopy has allowed 3-D optical imaging in 
vivo of tissue at greater depth than confocal microscopy, with very precise geometric 
localisation of the fluorophore and high spatial resolution [8]. This minimizes problems 
such as scattered light from out-of-focus regions, associated with conventional 
fluorescence microscopy [9]. To take full quantitative advantage of this technique we 
have applied image processing and kinetic analysis techniques to obtain estimates of Ki, 
the vascular leakage or tissue influx rate constant into tumour tissue of intravenously 
administered fluorescent dextran. In addition, the capillary vascular surface area, S, and 
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the vascular volume, Vvess, within a given tumour volume, V, were measured to enable 
calculation of an apparent vascular permeability, P.  
The second aim of the study was to investigate the effect of the tumour vascular 
disrupting agent, combretastatin A-4-phosphate (CA-4-P) on tumour vascular 
permeability. CA-4-P is a tubulin binding agent, which has been shown to depolymerise 
the tubulin cytoskeleton of vascular endothelial cells in vitro, within minutes of drug 
exposure, and to selectively shut down tumour blood flow in vivo [10-13]. These vascular 
disrupting effects led to its entry into clinical trials as an anti-cancer agent in 1998, where 
it is currently being tested in combination with conventional chemo- and radiotherapy. It 
has been hypothesised from in vitro data [14] that an increase in vascular permeability to 
macromolecules is an early effect of CA-4-P in vivo, indicative of vascular damage. 
Indeed, we have previously reported a relative increase in tumour extravasation of a 
macromolecular radiotracer following CA-4-P treatment [12]. However, we were unable 
to obtain absolute rates of extravasation in that study and the spatial resolution was 
poor. Here we report application of the above multiphoton fluorescence microscopy 
technique to the quantitative estimation of the apparent vascular permeability of tumour 
micro-vessels following CA-4-P treatment. 
 
MATERIALS AND METHODS 
Overview 
The P22 rat sarcoma was grown in transparent dorsal skin flap ‘window’ chambers to 
provide optically accessible tumour preparations for multiphoton fluorescence 
microscopy. 3-D images of the leakage of intravenously administered 40 kDa FITC-
dextran into the tumour extra-vascular space were obtained over time in CA-4-P and 
saline-treated rats. Image-processing techniques were applied to segment the images 
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into intra- and extra-vascular tissue classes. A kinetic analysis was applied to the time-
courses of fluorescence in these classes to obtain estimates of parameters relating to 
vascular permeability. 
Animals and Tumours 
The experiments were performed in male BDIX rats aged 6-8 weeks, weighing 
approximately 200 g. All animals were bred in house. All animal procedures were carried 
out in accordance with the UK Animals (Scientific Procedures) Act 1986 and with 
approval of the Ethical Review Committee of the Gray Cancer Institute. Single small 
fragments (approximately 0.5 x 0.5 x 0.5 mm3) of early generation P22 rat sarcomas 
grown subcutaneously in donor rats were placed in contact with connective tissue held in 
transparent window chambers surgically implanted into the dorsal skin flap of recipient 
rats. Details of this technique have been described previously [12]. Immediately following 
surgery, animals were given an intra-peritoneal (i.p.) injection of 2 ml of dextrose saline 
and allowed to recover from anaesthesia on a warm pad. The animals were 
subsequently kept in a warm room, 32 – 34 oC, until the day of the experiment. The 
tumours were allowed to establish over a period of 10-14 days after surgery to a 
diameter of 2 to 4 mm. 
Preparation of Fluorophores 
FITC-dextran (40 kDa, 0.013Mol FITC/Mol dextran)  (Sigma, Poole, UK) was made up 
in phosphate buffered saline (PBS) and washed through a 30 kDa spin filter at 4000 rpm 
in a Sorvall RC-5B refrigerated fixed angle superspeed centrifuge (Dupont, Stevenage, 
UK). Two washes of 4 hrs and one of 16 hrs were applied to remove any free FITC or 
low molecular weight contaminants. The high molecular weight component was re-
suspended in PBS after each wash and used for investigation of fluorophore stability or 
multiphoton fluorescence microscopy, as described below. 
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Fluorophore stability 
Non-tumour-bearing rats were surgically anaesthetized using a mixture of fentanyl-
citrate (0.32 mg/kg) and fluanisone (10 mg/kg; Hypnorm; Janssen Animal Health) and 
midazolam (5 mg/kg; Hypnovel; Roche, Welwyn Garden City, United Kingdom) and kept 
warm with a thermostatically controlled heating blanket. One tail vein and one tail artery 
were cannulated and 0.1ml of heparin (100 IU) followed by 40 mg/kg (20 mg/ml) FITC-
dextran were injected intravenously. Blood samples (0.5 ml) were taken via the arterial 
cannula at various time-points up to 2 hours following fluorophore injection. Blood cells 
were removed by spinning at 3000 rpm for 5 minutes. 0.2 ml of plasma from each 
sample was diluted to 1ml in PBS and centrifuged through a 30 KDa spin filter (Millipore, 
Watford, UK), separating the plasma into two fractions, one containing high molecular 
weight (> 30 KDa) and one containing low molecular weight (< 30 KDa) fluorescent 
components. Both high and low molecular weight components were then measured for 
fluorescence intensity using a spectrometer (Perkin Elmer, Beaconsfield, UK). Samples 
were excited at 450 nm and fluorescent emission collected between 470 nm and 650 
nm. 
Multiphoton Intravital Microscopy  
Rats were surgically anaesthetized and kept warm as above. A tail vein was 
cannulated to permit intra-venous administration of the FITC-dextran. 0.5 ml FITC-
dextran, at a concentration of 20mg/ml, was injected via the venous cannula as a bolus 
over 2-3 seconds, immediately prior to image acquisition. Image acquisition was 
instigated as soon as the microscope could be focused on the fluorescence, 
approximately one minute after injection.  
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Microscopy was performed with a multiphoton microscope system developed in-
house, although commercial systems with similar specifications are now available. The 
in-house system was based on a modified Bio-Rad MRC 1024MP workstation, 
comprising a solid state pumped (10 W Millennia X, Nd:YVO4, Spectra Physics), self 
mode locked Ti:Sapphire (Tsunami, Spectra Physics) laser system, a focal scan head, 
confocal detectors and an inverted microscope (Nikon TE200). Enhanced detection of 
the scattered component of the emitted (fluorescence) photons is enabled by the use of 
three, non-descanned detectors, situated in the re-projected stationary plane. Due to 
geometrical constraints of the animal model, a long working distance objective was used; 
all images were captured with a 10x Nikon Plan Fluor objective (16 mm WD, 0.3 NA). 
Data collection 
CA-4-P (30 mg/kg) or an equivalent volume of saline was administered i.p. 
immediately prior to injection of fluorophore. Multiphoton fluorescent images were 
collected every 4 minutes, at a working excitation wavelength of 890 nm. Emission 
wavelength was 530 nm to 540 nm. 
The 3-D data consisted of 512 x 512 x 11 voxels each of volume 2.6 x 2.6 x 4.5 µm3. 
Fluorescence intensity, captured by the acquisition process, was assumed to be directly 
proportional to the number of molecules of the fluorescent marker. 15 time-frames were 
acquired over 60 minutes. Figure 1 shows the acquisition process graphically and 
illustrates the marker leaking from the intra-vascular tissue over time. A total of 15 
animals were imaged, of which 9 were treated with CA-4-P, and 6 were controls.  
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Image Pre-processing 
Pre-processing of the data was required to address two important problems: 
presence of noise, and tissue movement with time. All the image and statistical 
processing was performed in MATLAB (The Mathworks, USA ©).  
In order to reduce the noise in the 3-D volumes, a standard Oct Tree [15] averaging 
was performed, where the intensities of a number of neighbouring elements, 8 voxels in 
our case, are averaged. This procedure was carried out once, so that the final analysis 
was performed on 256 x 256 x 6 voxels.  
In order to correct for tissue movement, a tissue registration process was employed. 
The window chamber glass limited the movement of the tissue in the third dimension, 
reducing the degrees of freedom. Therefore, in most cases, the registration (i.e. 
correction of the image motion) was performed with a rigid body registration. In these 
cases, the whole image in each time-frame was moved and aligned to match the image 
in the previous time-frame. In a few cases, the tissue movement was not uniform, with 
parts of the image moving in different directions over time. In these cases, the data was 
partitioned into 15 x 15 regions of 32 x 32 x 6 voxels with 50% overlap and a local rigid 
body registration was performed for each of them individually. For both scenarios, the 
displacement of the data was analysed and corrected through cross correlation [16]. 
Cross correlation is a measurement of similarity or ‘matching’ between two signals; if two 
signal are identical, their relative similarity at the origin will be 1; if they are different, 
relative similarity will be less than 1, and if one of them has moved, the relative similarity 
will present a maximum value displaced from the origin according to the movement of 
the signal. The accuracy of the registration was assessed visually, which is a generally 
accepted method [17].  
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Segmentation 
Following pre-processing corrections, the images corresponding to the first time point 
were segmented into intra-vascular and extra-vascular classes using a double threshold 
masking technique as described below. The masks, defining the class to which each 
voxel from the corresponding intensity image belonged were applied to all subsequent 
intensity images of the same tumour in order to obtain intensity versus time within both 
intra-vascular and extra-vascular classes. 
Voxels below a lower threshold were classified as extra-vascular, and those above a 
higher threshold were classified as intravascular. Lower and higher thresholds were first 
set to enclose 50% and 95% of the voxels respectively. Optimisation of the threshold 
levels for each data set was then obtained by manual adjustment based on a visual 
inspection of the segmented classes. The remaining voxels, between these two levels, 
were then classified as follows. 
The intra-vascular class was smoothed by a convolution (i.e. a weighted average of 
each voxel and its neighbours sometimes called a Local Energy Function) with a [3 x 3 x 
3] Gaussian kernel [18]. This gives rise to a boundary region, defined as voxels adjacent 
to the intra-vascular class, hence allowing the surface area (in cm2) of the vessels (S) to 
be calculated. The volume (in cm3) of the vessels (Vvess) was calculated by the sum of the 
number of voxels of the intra-vascular class. Finally, isolated elements were eroded and 
reassigned to the class of their neighbours [19]. Remaining voxels were classified as 
uncertain. 
Validation of the segmentation algorithm 
Images from the first time-frame from two tumours were segmented manually using 
methodology described previously [20], without any knowledge of classification obtained 
by the segmentation algorithms described above. Briefly, manual segmentation of the 
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images involved placing a series of points by eye along the length of individual vessels, 
at the estimated mid-point between the vascular walls, and recording the (x,y,z) co-
ordinates. Wherever a vessel branching point was found, it was marked and a new trace 
started. A ‘vessel’ was defined as the length traced between two branching points. The 
average number of points in a vessel was approximately 10. The first tumour set 
required 1415 points in 124 vessels and the second set required 3292 points in 385 
vessels. The (x,y,z) coordinates of these points were then used to determine whether the 
current segmentation technique allocated them correctly. A vessel was considered as 
identified correctly if more than 50% of the manually described points for that vessel 
were found within either the intra-vascular or boundary classes. 
Kinetic analysis of extravasation 
Segmentation allowed the extraction of fluorescence intensity-time curves for the 
intra-vascular class (capillary input function) and the corresponding curve for the extra-
vascular class (tissue response function). In order to simplify the kinetic analysis of this 
extravasation data, we employed a graphical representation originally described by 
Patlak et al. [21], which is widely used in quantitative imaging studies [22], such as those 
employing magnetic resonance imaging (MRI)  ([23-25]) and positron emission 
tomography (PET) [26-29]. This method involves a transformation of the data such that 
the ratio of extra-vascular intensity to intra-vascular intensity is plotted against a modified 
time axis, which effectively transforms the data into that which would have been 
observed had the capillary input function been constant throughout the experiment. This 
transformation greatly simplifies the analysis. When there is a net irreversible 
accumulation of fluorescence in the tissue over the time course of the experiment, it 
follows that the plot becomes linear after sufficient equilibration time. Also, the terminal 
slope of this line is equal to the rate constant describing the net irreversible transport of 
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the fluorescence from the capillary to the tissue (Ki) [21]. See also Padhani and Choyke 
[22] for a text-book description of the Patlak approach. 
The modified time axis in this plot is calculated as follows [21]: for each real time 
point, t, of the experiment, the modified time, T, is given by the integrated concentration 
of marker in blood up to time t divided by the actual concentration of the marker at time t. 
Therefore, for our data, the Patlak plot is given by y =
Ct (t)
Cvess(t)
 against T =
C
vess
(t)dt∫
C
vess
(t)
 , 
where Ct(t) is fluorescence intensity in the extra-vascular class and Cvess(t) is fluorescence 
intensity in the intra-vascular class at time t. In order to fit the transformed data and 
obtain an estimate of the terminal slope, we used an equation describing an exponential 
approach to a straight line y = α + βT( ) 1− e−γT( ) , with variables α, β and γ, where the 
slope of this straight line, β, is the estimate of Ki. Data were fitted using non-linear least 
mean squares. The average time required for image processing and kinetic analysis 
algorithms, from the intensity data to Ki for each tumour, was of the order of minutes. 
Estimation of Apparent Permeability 
Since the resolution of multiphoton fluorescence microscopy allowed the 
measurements of the input function to be performed directly in the microvessels, 
estimates of an apparent vascular permeability, P, were obtained from the relationship Ki  
=  PS/V (in sec -1) [30-32], where S is vascular surface area for exchange in a volume V of 
exchanging tumour tissue, obtained from the image analysis described above.  
Statistics   
A Student's t-test was used to test the significance of the difference in means 
between the control and CA-4-P-treated groups for the different permeability parameters. 
The analysis was performed using MATLAB's Statistics Toolbox. 
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RESULTS 
Fluorophore stability 
5 minutes after intravenous administration of 40 kDa FITC-dextran, the high molecular 
weight component (> 30kDa) of plasma fluorescence accounted for 99.8% of the total 
fluorescence measured in rat plasma. This percentage remained constant throughout 
the time-course of the experiment (2 hours). Total plasma fluorescence decreased from 
approximately 4 x 104 to 2.5 x 104 fluorescence intensity units, over the same time-scale, 
presumably due to tissue uptake and metabolism. Maintenance of the high molecular 
weight component of fluorescence over this time-scale provided evidence for in vivo 
stability of the FITC-dextran used in the imaging studies.  
Image Pre-processing 
The tissue movement with time of one of the data sets is presented in two different 
ways in figure 2; first as a ‘time cut’ (figure 2 (a)) and then as one dimensional (1-D) lines 
(figure 2 (b)). In figure 2 (a), the top image is the time cut, formed by selecting a line of 
intensity values from the same position in each of the intensity images and placing the 
lines from images belonging to adjacent time points next to each other. Intensity images 
from three separate time points are shown in the lower panels in figure 2 (a). It can be 
seen that the intensities for the chosen line shift upwards and later downwards with time, 
indicating tissue movement. Another characteristic of the time cut shown is the 
decreasing contrast in intensities with time, indicating leakage of FITC-dextran from the 
intra-vascular to extra-vascular space. Figure 2 (b) shows two 1-D signals corresponding 
to one line of voxels from the time cut at two different time points. The tissue movement 
is revealed by a clear shift to the left of the intensity profile with time.  
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Figure 3 illustrates the results for cross correlation, used in image registration to 
correct for tissue movement with time. The relative similarity of the two 1-D signals 
shown in figure 2 (b) is presented in figure 3 (a). The peak of the cross correlation, 
indicating 95% relative similarity, is shifted towards the right of the centre, indicating 
movement i.e. the line in the image at the second time point is most similar to the 
selected line in the first image when it has moved to the right by approximately 20 µm. In 
figure 3 (b) the cross correlation of two 2-D signals is presented as a 3-D mesh and 
again it can be seen there is a shift in the rows, while there is no apparent movement in 
the columns. The arrow indicates the movement of the tissue, so that its registration was 
performed by a shift in the inverse direction. 
Figures 3 (c, d) show two different registration maps, the first corresponds to a case 
where rigid registration would correct the movement of the tissue and the second 
corresponds to a movement that requires a non-rigid registration to compensate for the 
movement of the tissue. The maps were obtained by partitioning the data into 15 x 15 
regions of 32 x 32 x 6 voxels as described in Materials and Methods. Each arrow 
denotes the correction required for each region of the partition. Finally figure 3 (e) shows 
a time cut image of the registered data derived from the raw data shown in figure 2 (a). 
The registration process has turned the curved lines corresponding to the bright intra-
vascular tissue into straight lines. 
Validation of the segmentation algorithm 
The semi-automated segmentation algorithm described above, applied to all 15 
tumour data sets, gave overall classification of voxels as 8.8% intra-vascular, 67.8% 
extra-vascular, 18.1% boundary, and 5.3% uncertain. 
Two tumour sets were used for validation, as described in Materials and Methods. In 
the first tumour, 12.9% of the vessels were designated incorrectly as extra–vascular and 
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87.1% were designated correctly as intra-vascular. For the second set, the results were 
7.0% and 93.0% respectively. Figure 4 shows the semi-automated segmentation, as a 3-
D rendering of the class masks for two tumours (a, b), the maximum intensity projections 
for both sets (c, d) and the results of the comparison between semi-automated 
segmentation and manual vessel identification (e, f). In e) and f), the vessels labelled in 
white and black indicate correct and incorrect classification by the semi-automated 
algorithm respectively. The vessels that were classified incorrectly were mainly due to 
vessels with very low intensity, as indicated by the arrows in Figure 4 for example.  
To evaluate the effect of omitting the incorrectly classified vessels in the analysis, we 
measured the average fluorescence intensities of the hand-segmented vessels for both 
tumours, firstly using only the correctly classified vessels and secondly using all the 
vessels. In the first tumour, the average intra-vascular fluorescence intensity was 51.6 
for correctly classified vessels only and 48.3 for all vessels. In the second tumour, the 
corresponding values were 41.9 and 40.6. The corresponding extra-vascular levels were 
19 for the first tumour and 8.7 for the second. The difference in intensities calculated by 
the two segmentation methods accounted for a variation of 6.4% and 3.2% in the Ct/Cvess 
ratio for the two tumours respectively, and therefore had minimal impact on calculations 
of the apparent vascular permeability. 
Estimation of Apparent Tumour Vascular Permeability 
The time-courses of intra- and extra-vascular fluorescence intensity are illustrated in 
figure 5 (a) with one control and one CA-4-P treated tumour. The intra-vascular intensity 
(Cvess) decreased rapidly in the first 20 minutes of the experiment, as expected due to 
whole body clearance of FITC-dextran. There was a significant difference in the rate of 
extravasation of the marker between controls and CA-4-P-treated tumours. As shown in 
Table 1, there was a significant difference between the two groups in the ratio Ct/Cvess at 
the final time point.  The rate of extravasation was also quantified in a Patlak analysis, as 
 15 
described in Materials and Methods. Figure 5 (b) shows representative Patlak plots for 
the same control and CA-4-P-treated tumours as in figure 5 (a). As described previously, 
in these plots, the Ct/Cvess ratio is plotted against a modified time axis T, equivalent to a 
tissue response to a constant concentration of the fluorescence marker in the 
vasculature. The linear increase in the ratio is indicative of a net irreversible 
accumulation of the marker in the extra-vascular regions of the tumour. The terminal 
slope of the line, Ki, was significantly greater in the CA-4-P-treated tumours than in the 
controls, as shown in Table 1 and figure 5 (c).  
The vessel volume and surface area per unit tumour volume ( Vvess/V ) and (S/ V) 
respectively were also calculated and values are given in Table 1. A mean value of 
0.083 for Vvess/V in control tumours or 0.091 for the CA-4-P-treated tumours at the start of 
the experiment (Table 1) are reasonable values for vascular volume for the well-
vascularised P22 tumour and is similar to the value reported by Yuan [9] for a different 
tumour model. The value for S/V enables expression of the rate of extravasation in terms 
of the capillary surface area, to give an apparent permeability P, where, P equals Ki x 
V/S. P was significantly greater in the CA-4-P-treated tumours than in the control 
tumours, as shown in Table 1 and figure 5 (d). The impact of the segmentation 
thresholds was assessed by varying the optimum thresholds for each set and re-
calculating P. No significant difference was detected for variations of  ± 2 in the grey 
level intensity (approximately 10% of the optimal value) in the levels of both thresholds 
(results not shown). 
 
DISCUSSION 
The present work builds on the inherent properties of multiphoton fluorescence 
microscopy for measuring the precise spatial localization of fluorescence at depth in 
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tissue. Application of image processing and kinetic analysis techniques to multiphoton 
fluorescence images of the uptake of a fluorescent marker into tumour tissue allowed 
estimation of the apparent tumour vascular permeability and its modification following 
vascular-targeted treatment. 40 kDa FITC-dextran was found to have prolonged stability 
in rat plasma. In contrast, we have found that administration of FITC-labelled albumin to 
rats results in a significant proportion of fluorescence in a low molecular weight fraction 
of plasma, within 20 minutes of injection, suggestive of significant instability of this 
molecule in vivo (unpublished data).  
There are several advantages of the methodology used here. The high spatial 
resolution of optical techniques allows direct segmentation of the intra-vascular input 
function from the tissue response function. This avoids the confounding effect that blood 
flow has on the interpretation of Ki, when the input function is either assumed or 
measured in great vessels, as used in other lower resolution imaging modalities such as 
magnetic resonance imaging and positron emission tomography. Had the input function 
been measured in arterial blood then it would have been necessary to take into account 
the effects on Ki of both blood flow rate and the transport rate across the capillary walls, 
as modelled for example in the Renkin-Crone equation [30,31]. The high spatial 
resolution of optical techniques combined with the use of multiphoton fluorescence for 
obtaining 3-D images also allows supplementary measures of capillary surface area and 
volume to be taken into account when interpreting Ki in terms of apparent permeability, 
P. Because of the acquisition of 3-D images, this does not involve any assumptions 
regarding vessel diameter in the depth dimension. Furthermore, the semi-automated 
method used here allows full use to be made of the 3-D data set instead of manual 
selection of a very small sub-set of blood vessels within the imaged volume. User 
intervention is required only for setting the intensity thresholds, and no vessel selection 
or repositioning is required. The segmentation and analysis with the proposed 
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methodology takes a matter of minutes, whilst manual tracing of blood vessels within a 
tumour, as described in [20] takes many hours. Furthermore, it was possible to minimize 
movement effects by application of image registration techniques to images obtained at 
consecutive time points.  
Two important observations regarding the segmentation technique used in the current 
study arise at this point. First, even if parts of vessels were incorrectly classified as 
extra-vascular tissue, those regions that were classified as intra-vascular were almost 
certainly correct such that the numbers of false positives were very low. Clearly, if the 
upper threshold that defines the intra-vascular tissue were lowered, more points would 
belong to this class, but at the same time the number of false positives would also rise, 
lowering the specificity of the method. Second, the geometry of the vasculature was only 
of secondary interest for this work; such that disjointed or broken vessels could be 
tolerated for estimation of Ki, as long as the average intensity of each class was 
determined accurately. In other words, the sensitivity of the method to distinguish 
vessels with low intensity is less crucial than the correctness of classes it detects. 
Graphical representation of leakage data, as described by Patlak et al. [21], is a 
useful analysis tool as it avoids the use of complex pharmacokinetic modelling, in the 
case of net irreversibly accumulation of a marker in the extra-vascular space. In addition, 
in our case, it allows easy visual assessment of the effect of CA-4P, which is not 
immediately apparent from inspection of the original time-activity curves, where the 
capillary input function is not constant. The early part of the transformed curves, such as 
the ones shown in Figure 5b), cannot be accurately defined because of the time required 
to focus the microscope. However, this is not critical because it is the terminal slope of 
the ‘Patlak plot’ from which estimates of Ki are obtained.  
Our estimation of apparent permeability, P, derives from Ki = PS/V [32]. We have 
denoted P as an apparent permeability because its relationship to the true physico-
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chemical permeability for the chosen marker requires several qualifications, which are 
often ignored in the literature. Strictly, the concentration of the intra-vascular fluorescent 
marker should be expressed relative to plasma rather than whole blood. This correction 
to the estimate of P would require knowledge of the haematocrit in individual micro-
vessels. We have also assumed that the Ki is limited by the uni-directional transport of 
the fluorophore from capillary across the vascular wall and that there is no significant 
reversible exchange occurring during the time-course of the experiment. We aimed to 
minimize these effects by the use of a high molecular weight marker but we cannot 
discount their existence. In the presence of reversible exchange of the fluorophore 
across the capillary wall, the Ki would represent a lower bound estimate for PS/V. Finally, 
we refer to P as an apparent permeability because an unknown proportion of leakage 
occurs via convection currents. This is discussed in more detail below, with respect to 
the CA-4-P-induced increase in Ki.  
In [33] Gerlowski reported vascular permeability (P) measurements of 5.72 ± 3.92 x 
10-7 cm/s for FITC-dextran 150 (150 kDa) in tumours grown in rabbit ear chambers. In [2] 
Monsky reported 3.2 ± 13 x 10-7 cm/s (mammary fat pad) and 1.3 ± 0.5 x 10-7 cm/s 
(cranial window) for tetramethylrhodamine-labeled BSA in ZR75-1 tumours growing in 
different microenvironments in female severe combined immunodeficient (SCID) mice. In 
[9] Yuan reported 6.06 ± 4.30 x 10-7 cm/s for Texas Red-BSA (67 kDa) in human 
adenocarcinoma LS174T in SCID mice. Our value for untreated tumours was 12.76 ± 
3.36 x 10-7 cm/s. Therefore, given the different animals, markers, molecular weights, 
imaging modalities and tumour lines used in the studies, our estimates of the apparent 
vascular permeability are of the same order as these published data. All these estimates 
were obtained using conventional fluorescence microscopy and are subject to the 
qualifications described above.  
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Both Ki and P were higher in the CA-4-P-treated group compared with controls. The 
effect of CA-4-P on Ki clearly demonstrates that the leakage rate of FITC-dextran from 
blood to the extra-vascular tumour space is increased after CA-4-P treatment, which 
implies a generalized protein leak into the tumour tissue, as previously proposed [12]. 
Clearly, differences in charge, size and shape of dextran compared with plasma proteins 
such as albumin means that the absolute P for these various macromolecules differ. 
However, an increase in P for dextran is highly suggestive of an increase in P for plasma 
proteins of similar molecular weight. The calculations of P from Ki required additional 
calculations of S and V from the segmented images, thus potentially introducing further 
uncertainties in the estimates of P. However, the p-value obtained when P was 
compared for the CA-4-P treated and control groups was low enough to reject the 
hypothesis that the two groups belonged to a single distribution.  
The CA-4-P-induced increase in apparent permeability P strongly implies that CA-4-P 
disrupts the barrier function of tumour blood vessels. It should be pointed out that, as for 
several previous studies using the window chamber model, high tumour pressure 
imposed by the chamber glass could affect the absolute values of P obtained. Similarly, 
systemic cardiovascular effects of dextrans could affect the absolute values [34]. 
However, in terms of the effect of CA-4-P on P, both the control and treated groups were 
exposed to similar conditions, such that the statistical discrimination that was found 
between the two groups is robust. In addition, we cannot dismiss the possibility that 
there was an increase in fluid convection across the vascular wall following CA-4-P 
treatment, which could contribute to the observed increase in P. This may occur as a 
result of an increase in tumour perfusion pressure subsequent to a CA-4-P-induced 
increase in mean arterial blood pressure, as reported previously in rats [35]. Finally, a 
limitation of the method is that the values of permeability correspond to an average of all 
vessels within the data, thus ignoring regional differences in permeability. This could be 
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analysed separately, but the partitioning of the data would increase the uncertainty of the 
measurements of surface area and volume, as a lower number of elements would be 
used for the calculations.  
In summary, the multiphoton fluorescence imaging method described allows accurate 
estimation of the tissue influx (vascular leakage) rate constant, Ki further allowing 
estimation of the apparent tumour vascular permeability, P, for an intravenously 
administered high molecular weight marker, with minimal user intervention and fewer 
assumptions than for other imaging methods with lower spatial resolution. In addition, 
results showed a significant increase in Ki and P following treatment with CA-4-P, which 
is consistent with our in vitro data and may act as a trigger for tumour blood flow 
reduction. 
 
ACKNOWLEDGEMENTS 
We would like to thank the Biological Services staff at the Gray Cancer Institute for care 
of the animals and Cancer Research UK for funding this work. 
 
REFERENCES 
1. Jain RK: Delivery of novel therapeutic agents into tumours: physiological barriers 
and strategies. JNCI 1989;81:570-576. 
2. Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, Jain RK: 
Role of host microenvironment in angiogenesis and microvascular functions in 
human breast cancer xenografts: mammary fat pad versus cranial tumors. 
Clinical Cancer Research 2002;8:1008-1013. 
3. Tozer GM, Kanthou C, Baguley BC: Disrupting tumour blood vessels. Nat Rev 
Cancer 2005;5:423-435. 
4. McDonald DM, Baluk P: Significance of Blood Vessel Leakiness in Cancer. 
Cancer Research 2002;62:5381-5385. 
5. Baird LC, Canoll P, Bruce J: Effect of infiltrating tumor cells on the blood-brain 
barrier in a neonatal rat glioma model. In Society for Neuro-Oncology Eighth 
Annual Meeting. Keystone, Colorado, 2003. 
6. Nakano S, Matsukado K, Black KL: Increase brain tumor microvessel 
permeability after intracarotid bradykinin infusion is mediated by nitric oxide. 
Cancer Research 1996;56:4027-4031. 
 21 
7. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG: Molecular 
regulation of the bovine endothelial nitric oxide synthase by transforming growth 
factor-beta 1. Arterioscler Thromb Vasc Biol 1995;15:1255-1261. 
8. Masters BR, So PTC: Antecedents of Two-Photon Excitation Laser Scanning 
Microscopy, Microscopy Research and Technique. Microscopy Research and 
Technique 2004;63:3-11. 
9. Yuan F, Leunig M, Berk DA, Jain RK: Microvascular permeability of albumin, 
vascular surface area, and vascular volume measured in human 
adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 
1993;45:269-289. 
10. Dark GD, Hill SA, Prise VE, Tozer GM, Pettit GR, Chaplin DJ: Combretastatin A-
4, an agent that displays potent and selective toxicity toward tumor vasculature. 
Cancer Res. 1997;57:1829-1834. 
11. Grosios K, Holwell SE, McGown AT, Pettit GR, Bibby MC: In vivo and in vitro 
evaluation of combretastatin A-4 and its sodium phosphate prodrug. Br. J. 
Cancer 1999;81:1318-1327. 
12. Tozer GM, Prise VE, Wilson J, Cemazar M, Shan S, Dewhirst MW, Barber PR, 
Vojnovic B, Chaplin DJ: Mechanisms associated with tumor vascular shut-down 
induced by combretastatin A-4 phosphate: intravital microscopy and 
measurement of vascular permeability. Cancer Res 2001;61:6413-6422. 
13. Tozer GM, Prise VE, Wilson J, Locke RJ, Vojnovic B, Stratford MRL, Dennis MF, 
Chaplin DJ: Combretastatin A-4 phosphate as a tumor vascular-targeting agent: 
early effects in tumors and normal tissues. Cancer Res. 1999;59:1626-1634. 
14. Kanthou C, Tozer GM: The tumor vascular targeting agent combretastatin A-4-
phosphate induces reorganization of the actin cytoskeleton and early membrane 
blebbing in human endothelial cells. Blood 2002;99:2060-2069. 
15. Gaede V, Günther O: Multidimensional access methods. ACM Computing 
Surveys 1998;30:170-231. 
16. de Castro E, Morandi C: Registration of translated and rotated images using finite 
Fourier transforms. IEEE Transactions on Pattern Analysis and Machine 
Intelligence 1987;5:700-703. 
17. Hill DLG, Batchelor PG, Holden M, Hawkes DJ: Medical Image Registration 
[invited topical review]. Physics in Medicine and Biology 2001;46:R1-R45. 
18. Randen T, Husøy JH: Filtering for Texture Classification: A Comparative Study. 
IEEE Trans. on Patt. Anal. and Machine Intel. 1999;21:291-310. 
19. Schroeter P, Bigun J: Hierarchical Image Segmentation by Multi-dimensional 
Clustering and Orientation-Adaptive Boundary Refinement. Pattern Recognition 
1995;28:695-709. 
20. Barber PR, Vojnovic B, Ameer-Beg SM, Hodgkiss RJ, Tozer GM, Wilson J: Semi-
automated software for the three-dimensional delineation of complex vascular 
networks. J Microsc 2003;211:54-62. 
21. Patlak CS, Blasberg RG, Fenstermacher JD: Graphical evaluation of blood-to-
brain transfer constants from multiple-time uptake data. J Cereb Blood Flow 
Metab 1983;3:1-7. 
22. Padhani AR, Choyke PL: New Techniques in Oncologic Imaging.  Boca Raton 
FL, CRC Press, 2006. 
23. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, 
Brasch RC: Correlation of dynamic contrast-enhanced MR imaging with 
histologic tumor grade: comparison of macromolecular and small-molecular 
contrast media. AJR Am J Roentgenol 1998;171:941-949. 
 22 
24. Daldrup HE, Shames DM, Husseini W, Wendland MF, Okuhata Y, Brasch RC: 
Quantification of the extraction fraction for gadopentetate across breast cancer 
capillaries. Magn Reson Med 1998;40:537-543. 
25. Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC: Quantitative estimation 
of microvascular permeability in human brain tumors: correlation of dynamic Gd-
DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9 
Suppl 1:S151-155. 
26. Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, Enne W, 
Herz M, Nerl C, Garbrecht M, Schwaiger M: Positron emission tomography in 
non-Hodgkin's lymphoma: assessment of chemotherapy with 
fluorodeoxyglucose. Blood 1998;91:4464-4471. 
27. Smith IC, Welch AE, Hutcheon AW, Miller ID, Payne S, Chilcott F, Waikar S, 
Whitaker T, Ah-See AK, Eremin O, Heys SD, Gilbert FJ, Sharp PF: Positron 
emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the 
pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 
2000;18:1676-1688. 
28. Lodge MA, Lucas JD, Marsden PK, Cronin BF, O'Doherty MJ, Smith MA: A PET 
study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22-30. 
29. Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE: 
Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by 
positron emission tomography. Clin Cancer Res 2000;6:3837-3844. 
30. Renkin EM: Transport of potassium-42 from blood to tissue in isolated 
mammalian skeletal muscles. Am. J. Physiol. 1959;197:1205-1210. 
31. Michel CC, Curry FE: Microvascular permeability. Physiol Rev 1999;79:703-761. 
32. Bickel U: How to Measure Drug Transport across the Blood-Brain Barrier. 
NeuroRx 2005;2:15-26. 
33. Gerlowski LE, Jain R, K.: Microvascular permeability of normal and neoplastic 
tissues. Microvascular Research 1986;31:288-305. 
34. Briseid G, Briseid K: Inhibition by low molecular weight dextran of the blood 
pressure fall and the lowering of plasminogen proactivator induced by clinical 
dextran in the rat. Acta Pharmacol Toxicol (Copenh) 1983;52:143-149. 
35. Prise VE, Honess DJ, Stratford MRL, Wilson J, Tozer GM: The vascular 
response of tumor and normal tissues in the rat to the vascular targeting agent, 
combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol 
2002;21:717-726. 
 
 23 
TABLE 1 
 
Estimates of vascular parameters in P22 tumours grown in dorsal skin flap window 
chambers with/without treatment with combretastatin A-4-P (CA-4-P). (Ct/Cvess) is extra-
vascular versus intra-vascular fluorescence intensity ratio for the last time sample (t = 
58.5 min); Ki is the tissue influx (vascular leakage) rate constant; Vvess/V is the vascular 
volume per unit volume of tissue; S/V is the vascular surface area per unit volume of 
tissue; P is the apparent tumour vascular permeability calculated from Ki = PS/V. Mean 
values, standard deviation (SD), standard error of the mean (SEM) and p-values for a 
Student’s t-test between treated and untreated groups are also presented. Notice that 
while there is no statistical difference in the geometrical parameters (S/V, Vvess/V), the 
three indicators of permeability (Ct/Cvess, Ki, P) show a difference (p<0.05) between 
treated cases and controls. 
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Table 1 
Animal 
Number 
Group Ct/Cvess Ki *10
4
 Vvess/V S/V P * 10
7
 
   [1/s]  [1/cm] [cm/s] 
1 CA-4-P 0.968 3.695 0.107 84.1 43.914 
2 CA-4-P 0.795 2.061 0.067 49.9 41.258 
3 CA-4-P 0.691 2.252 0.097 86.0 26.202 
4 CA-4-P 0.700 3.095 0.096 107.8 28.711 
5 CA-4-P 0.808 2.062 0.093 76.7 26.874 
6 CA-4-P 0.797 2.456 0.091 92.8 26.471 
7 CA-4-P 0.732 2.350 0.075 91.8 25.607 
8 CA-4-P 0.659 3.224 0.118 85.3 37.796 
9 CA-4-P 0.708 2.096 0.077 96.9 21.638 
Mean  0.762 2.588 0.091 85.7 30.941 
SD  0.093 0.599 0.016 16.1 7.911 
SEM  0.03  0.20 0.005 5.4 2.64 
10 Control 0.579 1.164 0.054 54.6 21.323 
11 Control 0.460 0.492 0.082 108.9 4.516 
12 Control 0.608 2.154 0.121 93.9 22.938 
13 Control 0.563 2.039 0.117 134.8 15.123 
14 Control 0.388 0.639 0.070 80.6 7.930 
15 Control 0.661 0.278 0.056 58.9 4.721 
Mean  0.543 1.128 0.083 88.6 12.758 
SD  0.101 0.806 0.030 30.6 8.227 
SEM  0.04 0.33 0.01 12.5 3.36 
p-value  0.0008 0.0014 0.514 0.810 0.0009 
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FIGURES 
 
Figure 1. Time course of the acquisition of one 3-D volume (512 x 512 x 11 voxels 
corresponding to 1331.2 x 1331.2 x 50 µm3) of multiphoton images for one BDIX rat 
treated with CA-4-P. Intra-vascular tissue is bright at the first time point allowing its ready 
discrimination from surrounding tissue. Notice the reduced contrast in the tumour with 
time, as contrast agent leaks into the extra-vascular tissue. Time t = 1  was used to 
represent the start of image acquisition. The mid-point of each 3 minute imaging window 
was used to represent the acquired time for each image in all subsequent plots.  
 
Figure 2. (a) A time-cut (top image) to illustrate the tissue movement with time of one 
data set. Single columns (one voxel of width and depth) of data are extracted from 2-D 
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images at each time point and placed next to each other to form a new image, having 
the time as the horizontal axis. Three 2-D images from the whole time series are shown 
to illustrate the procedure. Dashed arrows indicate bright intra-vascular tissue in the first 
2-D image and its corresponding voxel in the first column. Solid vertical lines indicate the 
exact cut from where data for the columns are obtained and the solid arrows indicate the 
position on the column at which they are placed. The movement is manifest as the 
variation of the intensity upwards and then downwards with time. (b) Two 1-D lines 
corresponding to the intensity of the voxels of one of the columns selected above at two 
different time points (t = 2.5, 6.5 minutes). Notice the shift of the peaks to the left.  
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Figure 3. Registration of data through cross correlation. (a) The cross correlation of the 
two 1-D signals shown in figure 2 (b). The degree of movement of the signals is depicted 
by the maximum value of the relative similarity (close to 95%) being to the right of the 
central value. (b) Cross correlation of two 2-D signals displayed as a 3-D mesh. Notice 
again how the maximum is shifted from the centre. The movement in the direction of the 
rows is close to 20 µm, while there is no apparent movement in the direction of the 
columns. The arrow indicates the movement of the tissue. Rigid and non-rigid 
registration maps (c, d) denoting the direction of the displacement required to correct for 
the movement of the 15 partitioned regions of the data. (e) Registered time cut. The 
curved lines that revealed the temporal movement of the images in figure 2 (a) appear 
as straight lines in the registered set.  
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Figure 4. Comparison of the image segmentation algorithm with a manual method. (a, b) 
3-D rendering of the class masks for two tumours. Intra-vascular voxels are labelled in 
black, extra-vascular voxels in yellow and boundary region in blue, with a lighter shade 
for the voxels closest to the intra-vascular region. In these two tumours there were 
insignificant numbers of unclassified voxels. The rendering was performed with 
transparency and details of different slices can be seen. (c, d) Maximum intensity 
projection of the intensities of two data sets. The arrows point to regions of intra-vascular 
 30 
tissue with low intensities. (e, f) Comparison with manually segmented vessels. The 
vessels that were correctly segmented with the algorithm (those with more than 50% 
points correctly classified, see text) are labelled in white and those that were not are 
labelled in black. The arrows show two regions of low intensity where the segmentation 
with the proposed methodology detects less than 50% of the points of the manually 
segmented traces. 
 
Figure 5. (a) Time-activity curves of the intensities of intra-vascular tissue (Cvess(t)) and 
extra-vascular tissue (Ct(t)) versus time for two data sets, one control and one treated 
with CA-4-P. While Cvess decreased exponentially, Ct increased steadily. It was assumed 
that this increase is due to the extravasation of the marker. The vertical axis denotes 
average intensity in the intra- and extra-vascular regions and the horizontal axis denotes 
time after fluorophore injection. (b) Transformed time plots for the same control and CA-
4-P-treated tumours. Data from time-activity curves were transformed, as described by 
Patlak et al [21] (see text for details). The vertical axis denotes the ratio of intensities in 
the intra- and extra-vascular regions and the horizontal axis denotes an adjusted time, 
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such that the curves represent the intensity ratio versus time curves that would have 
pertained in each case had the input functions (Cvess versus time) been constant 
throughout the time-course of the experiment. The slope of the linear section of the plot 
provides the estimate of Ki. Notice that the treated case has a higher slope than the 
control. (c) Box plot  (lines at the lower quartile, median, and upper quartile values) of the 
Ki product for the two groups (1.13 ± 0.33 x 10
-4 sec-1 for the controls and 2.59 ± 0.20 x 
10-4 sec-1 for CA-4-P, p = 0.0014) and (d) Box plot of the apparent permeability P for the 
two groups (12.76 ± 3.36 x 10-7 cm/s for controls and 30.94 ± 2.64 x 10-7 cm/s for CA-4-
P, p = 0.0009). Both box plots denote statistical difference between treated and control 
groups. 
 
